Sterile IV Containers Market Report 2025

This sterile iv containers market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The sterile iv containers market size has grown rapidly in recent years. It will grow from $5.72 billion in 2024 to $6.36 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to the need for more sophisticated healthcare facilities, a surge in demand for sterile intravenous (IV) containers, enhanced drug delivery, increasing patient safety concerns, and government initiatives and support.

The sterile iv containers market size is expected to see rapid growth in the next few years. It will grow to $9.59 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to rising healthcare spending, growth in hospital admissions, rising prevalence of chronic diseases, expansion of home healthcare services, and increasing awareness of infection control. Major trends in the forecast period include advancements in container technology, innovations in technology, supportive regulatory frameworks and standards, producers devoting resources to research and development, and demand for eco-friendly solutions.

The increasing adoption of home healthcare is anticipated to drive the growth of the sterile IV containers market. Home healthcare involves delivering medical and personal care services directly to patients' homes, offering a more personalized and convenient alternative to traditional healthcare settings. The surge in home healthcare is attributed to a demand for tailored care, advancements in medical technology, rising healthcare costs, and a shift towards managing chronic conditions and recovery at home. Sterile IV containers are crucial in home healthcare to ensure the safe and infection-free administration of intravenous treatments. For example, the Centers for Medicare & Medicaid Services (CMS) reported in December 2023 that spending on services from freestanding home health care agencies rose by 6% in 2022, reaching $132.9 billion, a significant increase from the 0.3% growth observed in 2021. This growth in home healthcare is fueling the demand for sterile IV containers.

Leading companies in the sterile IV container market are concentrating on creating innovative products, such as dual-chamber bags, to enhance drug stability, improve patient safety, and streamline the administration process for healthcare professionals. Dual-chamber bags are specialized sterile containers designed for the storage and delivery of medications, particularly in intravenous (IV) therapy. For example, in June 2022, Gufic Biosciences, an India-based pharmaceutical company, introduced a new drug delivery system that features dual-chamber bags. This advancement underscores the increasing emphasis on user-friendly and efficient sterile IV containers, which are becoming vital in healthcare environments, especially for medications that require precise preparation and administration just prior to use.

In January 2022, ICU Medical Inc., a US-based medical device company, acquired Smiths Medical for $2.35 billion. This acquisition aims to establish a leading infusion therapy company with an extensive global presence by integrating Smiths Medical's products into ICU Medical's portfolio. The move is intended to enhance stability in the medical supply chain and expand capabilities as clinical care models evolve. Smiths Medical, also based in the US, provides sterile intravenous containers.

Major companies operating in the sterile IV containers market are Cardinal Health Inc., Fresenius Kabi, Medline Industries Inc., Becton Dickinson and Company (BD), Baxter International Inc., Otsuka Holdings Co. Ltd., B. Braun SE, Terumo Medical Corporation, Nipro Corporation, West Pharmaceutical Services Inc., ICU Medical Inc., Kraton Corporation, Halyard Health, Renolit SE, Amsino International Inc., Technoflex, MedicoPack, Kiro Grifols, Sippex, Polycine GmbH.

North America was the largest region in the sterile IV containers market in 2023. The regions covered in the sterile IV containers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sterile IV containers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Sterile intravenous (IV) containers are medical-grade vessels specifically designed for holding IV fluids and medications that are directly administered into a patient’s bloodstream. These containers are sterilized to eliminate contaminants such as bacteria or pathogens that could lead to infections when the contents are infused into the body.

The primary types of sterile IV containers include pour bottles and flexible bags. Pour bottles are rigid, sterile IV containers that facilitate controlled fluid dispensing, making them suitable for use in hospitals and clinics where precise delivery of IV solutions is essential. They are constructed from materials such as non-polyvinyl chloride (PVC) and polyvinyl chloride (PVC), and are utilized in various settings, including hospitals, clinics, and ambulatory care centers.

The sterile IV containers market research report is one of a series of new reports that provides sterile IV containers market statistics, including sterile IV containers industry global market size, regional shares, competitors with a sterile IV containers market share, detailed sterile IV containers market segments, market trends and opportunities, and any further data you may need to thrive in the sterile IV containers industry. This sterile IV containers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sterile IV containers market consists of sales of sterile intravenous (IV) bags, pre-filled containers, y-site connectors, and needle-free valves. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.